Início › Sobrepeso › Virgínia

Ensaios clínicos de Sobrepeso em Virgínia

33 estudos para Sobrepeso estão buscando participantes em locais em Virgínia.

Cidades em Virgínia

Texto oficial do estudo (Inglês)

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

National Clin Res Inc., Richmond

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07533175

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Washington Center For Weight Management And Research /ID# 282047, Arlington
Sovah Health - Danville /ID# 282876, Danville
Health Research Of Hampton Roads /ID# 282014, Newport News
e mais 1

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07752979

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Washington Cntr Weight Mgmt, Arlington
Health Res of Hampton Roads, Newport News
National Clin Res Inc., Richmond

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07720271

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

York Clinical Research, LLC, Norfolk

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07595549

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

National Clin Res Inc., Richmond
Gastroent Consult of SW VA, Roanoke

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Sovah Clinical Research-River District, Danville
Clinical Research Partners, LLC, Richmond

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07794579

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Manassas

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

VCU Health - Center for Endocrinology Diabetes and Metabolism, Richmond

RecrutandoFase 3

Idades de 6 a 17 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Consultants of Southwest Virginia, Roanoke

RecrutandoFase 3

Idades de 18 a 70 · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06937086

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Inova Cardiology - Fairfax, Fairfax
Virginia Heart, Falls Church

RecrutandoFase 3

Idades de 45 a 99 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Charlottesville Medical Research, Charlottesville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07353931

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

AMR Clinical, Norfolk

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07321886

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Manassas
Research Site, Norfolk

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07784270

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Sovah Clinical Research-River District, Danville

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Hampton

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Hampton

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Manassas Clinical Research Center, Manassas
Centricity Research Suffolk Primary Care, Suffolk

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Burke
ACCOMPLISH-2 Research Site, Manassas
ACCOMPLISH-2 Research Site, Suffolk

RecrutandoFase 3Voluntários saudáveis bem-vindos

Idades de 18 a 79 · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Selma Medical Associates, Winchester

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07770841

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
Clinical Research Partners, LLC, Richmond

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Sovah Clinical Research-River District, Danville

RecrutandoFase 2

Idades de 18 a 75 · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06143956

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Health Res of Hampton Roads, Newport News
National Clin Res Inc., Richmond
Selma Medical Associates, Winchester

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Manassas
Kailera Clinical Site, Richmond

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Danville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Washington Center for Weight Management and Research, Inc, Arlington
Health Research of Hampton Roads, Newport News
Selma Medical Associates, Winchester

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Manassas Clinical Research Center Inc, Manassas

RecrutandoFase 3

Idades de 18 a 99 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT07684144

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Arlington

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Health Res of Hampton Roads, Newport News

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07509307

Advancing Water Security: A Community Participatory School-Based Hydration Intervention

Children's Hospital of Richmond at VCU Healthy Lifestyles Center, Henrico

RecrutandoVoluntários saudáveis bem-vindos

Idades 4 e acima · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT06714929

Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes

University of Virginia, Charlottesville

RecrutandoVoluntários saudáveis bem-vindos

Idades de 21 a 50 · Todos os sexos · Atualizado em 7 de mai. de 2026 · NCT07573228

Examining Valence-based Effects in Self-Monitoring Feedback Messages

University of Virginia, Charlottesville

RecrutandoVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 31 de mar. de 2026 · NCT07292389

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

University of Virginia, Charlottesville

RecrutandoVoluntários saudáveis bem-vindos

Idades de 30 a 55 · Todos os sexos · Atualizado em 23 de mar. de 2026 · NCT04791371

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

UVA Student Health and Wellness Building, Charlottesville

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de dez. de 2025 · NCT06009276

Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.